Pain Relief, Mobility, and Long-Term Benefits

Back in late 2023, MBST Medical UK set out to see whether patient data supported our claims: does MBST live up to our claims? The short answer is: yes, it absolutely does.

So, we launched the first version of our Patient Survey, to capture some vital data. Data that could help us to improve and streamline the patient process/journey, whilst providing us with valuable insights into the efficacy of MBST therapy in alleviating pain, enhancing mobility, and improving overall quality of life.

The following blog presents the findings of the first 12 months of the survey, offering us a glimpse into patient demographics, rehabilitation progress, sleep quality, and overall satisfaction with the treatment. 

Summary of Findings
(for the skim-readers)

• Pain Relief:
Most patients experienced significant reductions in pain across all conditions,
particularly by the 10-week mark, with sustained relief at six months.

• Mobility Improvements:
Enhanced mobility was consistently reported, improving patients’
quality of life.

• Side Effects:
None of the surveys reported significant side effects, reinforcing the safety of
MBST therapy.

• Satisfaction:
Consistently high satisfaction across all conditions, reflecting patient
confidence.

Conditions

1. Osteoarthritis:

Patients reported significant reductions in pain and improved mobility over time.

Osteoarthritis is one of the most common conditions treated with MBST, so the survey provided us with a wealth of data, giving us invaluable insight into the patient’s journey from pre- to post-treatment.

Before treatment, most patients reported moderate to severe pain (7/10) and 65% struggled with daily tasks like walking and climbing stairs. Many had tried physiotherapy or medication with limited success.

After just three weeks, pain dropped to 4/10, with 70% noticing improved mobility. By ten weeks, pain reduced to 2/10, and 85% had regained movement, returning to activities they had previously avoided. These improvements were sustained at six months, with 90% of patients highly satisfied with their results.

• Progressive pain reduction.
• Long-term improvements in mobility.
• Consistent satisfaction rates, reflecting confidence in the treatment.

2. Osteoporosis:

Gradual improvements in bone stability, confirmed through follow-up scans.

Before treatment, patients experienced moderate to severe pain (6.8/10), struggled with weight-bearing activities, and feared fractures. Many relied on bisphosphonates, often with concerns about side effects.

After just three weeks, pain decreased to 5/10, with improvements in confidence and mobility. By ten weeks, pain reduced further to 3/10, with 80% reporting better stability and less fear of fractures. At six months, the pain remained low at 2/10, and follow-up bone scans showed improved bone stability, reinforcing MBST’s role in long-term bone health.

• Gradual yet sustained pain relief.
• Improved mobility and reduced fear of fractures.
• Bone density improvements as indicated by follow-up scans.

3. Back Pain:

Pain levels decreased, with many patients reducing their reliance on painkillers.

Patients with severe, chronic pain often struggled with sitting or standing for long periods, making daily tasks difficult. Many had tried physiotherapy, chiropractic care, or painkillers, but only experienced temporary relief.

After just three weeks, pain decreased from 8/10 to 5/10, with 60% reporting better tolerance for sitting and standing. By ten weeks, pain dropped to 3/10, and 75% reduced their reliance on painkillers. At six months, the pain remained low at 2/10, with fewer flare-ups and improved spinal flexibility, allowing for greater ease of movement.

• Rapid pain reduction, followed by steady improvements.
• Enhanced mobility and reduced dependence on medication.
• Long-term gains in spinal flexibility and overall quality of life.

Key Insights:

• MBST is effective across multiple musculoskeletal conditions, particularly degenerative and chronic pain conditions.

• Follow-up data suggests gradual and sustained improvements well beyond the initial treatment period.

Pain Relief: Lasting Results

Before MBST, patients experienced moderate to severe pain (7/10), with little success from physiotherapy or medication.

After just three weeks, pain reduced to 4/10, with 70% noticing improvement. By ten weeks, pain dropped to 2/10, and 85% regained mobility. These results were sustained at six months and beyond, with 90% of patients highly satisfied.

Unlike medication, MBST targets the root cause, stimulating cellular repair for long-term pain relief without side effects.

Mobility: Regaining Independence

Before MBST, 65% of patients struggled with daily tasks like walking, climbing stairs, or standing for long periods.

After treatment, many regained mobility and confidence, returning to activities they had previously avoided. Patients with osteoarthritis and osteoporosis saw the greatest improvements in movement.

Beyond physical benefits, better mobility was found to enhance mental well-being and independence, and long-term results suggest MBST may help delay or even prevent the need for surgery.

Sleep: Restoring Quality Rest

Sleep and rest are essential for healing as they allow the body to repair tissues, reduce inflammation, and regulate hormones that support immune function and cellular regeneration. Before MBST, many patients struggled with falling and staying asleep due to pain.

After just three weeks, 50% reported better sleep, and by ten weeks, 75% experienced fewer interruptions and improved rest. These benefits were sustained at six months, with patients linking better sleep to long-term pain relief.

Patients also reported improvements in mood, energy levels, and overall well-being, highlighting the wider impact of pain reduction on daily life.

Safety and Patient Satisfaction

Patients reported zero significant side effects across all surveys, reinforcing MBST as a safe, non-invasive alternative to medication and surgery.

With 90% of patients expressing confidence in the treatment, satisfaction rates remain consistently high. Many had previously tried other treatments without success, and MBST provided them with long-term pain relief and mobility improvements, making it a trusted solution for managing chronic conditions.

Conclusion and Key Takeaways

What We Learned from 12 Months of Patient Data:

1) MBST significantly reduces pain, with average pain scores dropping from 7 out of 10 to 2 out of 10.

2) Patients reported major improvements in mobility and confidence, leading to greater independence.

3) Sleep quality improved for most patients, demonstrating broader benefits beyond pain relief.

4) No side effects were reported, reinforcing MBST as a safe and effective alternative to surgery or medication.

5) Patient satisfaction was consistently high, with 90% reporting positive experiences and lasting results.

Ongoing Steps:

– We will continue our research and the follow-up surveys will provide further insights into MBST’s long-term effects.

– We will also encourage more patient participation in surveys to help strengthen the evidence base for MBST therapy.

Interested in MBST? Find a clinic near you and experience the benefits yourself.